A new mutation, Ala1500 → Glu, responsible for type 2A von Willebrand disease

International Journal of Hematology

Volumn 72, Issue 4, 2000, Pages 512-516

  Wang, Yingchun ^a   Zhang, Jingyu ^a   Zhang, Wei ^a   Wan, Haiying ^a   Ruan, Changgeng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Expression; Genetic mutation; Site directed mutagenesis; Von willebrand disease

Indexed keywords

RECOMBINANT PROTEIN; VON WILLEBRAND FACTOR;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD CLOTTING TEST; CASE REPORT; CLASSIFICATION; FATHER; FEMALE; GENETICS; HUMAN; MALE; MIDDLE AGED; NUCLEOTIDE SEQUENCE; POINT MUTATION; SECRETION; VON WILLEBRAND DISEASE;

ADULT; AMINO ACID SUBSTITUTION; BLOOD COAGULATION TESTS; DNA MUTATIONAL ANALYSIS; FATHERS; FEMALE; HUMANS; MALE; MIDDLE AGED; POINT MUTATION; RECOMBINANT PROTEINS; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 0034574016     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Ginsburg D, Handin RI, Bonthron DT, et al. Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization. Science. 1985;228:1401-1406.
2. Bonthron DT, Handin RI, Kaufman RJ, et al. Of pre-pro-von Willebrand factor and its expression in heterologous cells. Nature. 1986;32:270-273.
3. Sadler JE, Gralnick HR. Commentary: a new classification for von Willebrand disease. Blood. 1994;84:676-679.
4. Ginsburg D, Sadler JE. Von Willebrand disease: a database of point mutations, insertions and deletions. Thromb Haemost. 1993; 69:177-184.
5. Lyons SE, Bruck ME, Bowie EJW, Ginsburg D. Impaired intercellular transport produced by a subset of type IIA von Willebrand disease mutations. J Biol Chem. 1992;267:4424-4430.
6. Englender T, Lattuada A, Mannucci PM, Sadler JE, Inbla A. Analysis of Arg834Gln and Val902Glu type 2A von Willebrand disease mutations: studies with recombinant von Willebrand factor and correlation with patient characteristics. Blood. 1996;87: 2788-2799.
7. Lyons SE, Cooney KA, Bockenstedt P, Ginsburg D. Characterization of Leu777Pro and Ile865Thr type IIA von Willebrand disease mutations. Blood. 1994;83:1551-1557.
8. Furlan M, Robles R, Lämmle B. Partial purification and characterization of a protease from human plasma, cleaving von Willebrand factor to fragment produced by in vivo proteolysis. Blood. 1996;87:4223-4234.
9. Tsai HM, Sussman II, Ginsburg D, Lankhof H, Sixma JJ, Nagel RL. Proteolytic cleavage of recombinant type 2A von Willebrand factor mutation R834W and R834Q: inhibition by doxycycline and by monoclonal antibody VP-1. Blood. 1997;89:1954-1962.